| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/29/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Bought 617,382 shares
@ $0.84, valued at
$518.6k
Bought 575,195 shares
@ $0.84, valued at
$483.2k
|
|
| 05/26/2023 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 05/26/2023 |
4
| Porter Derrell (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 05/26/2023 |
4
| Kapadia Sandip (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 05/26/2023 |
4
| Kamarck Michael E. (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 21,567 options to buy
@ $1, valued at
$21.6k
|
|
| 05/26/2023 |
4
| Islam Saqib (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 05/26/2023 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 05/26/2023 |
4
| Countouriotis Athena (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Chou William (President and CEO) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 608,615 options to buy
@ $1.08, valued at
$657.3k
|
|
| 04/05/2023 |
4
| King Simona (CFO) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 140,000 options to buy
@ $1.08, valued at
$151.2k
|
|
| 04/05/2023 |
4
| Forman Mark S (Chief Medical Officer) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 175,000 options to buy
@ $1.08, valued at
$189k
|
|
| 04/05/2023 |
4
| Cale Edgar B. (GC & Corporate Secretary) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 175,000 options to buy
@ $1.08, valued at
$189k
|
|
| 04/05/2023 |
4
| Fotopoulos Alexandros (Chief Technical Officer) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 175,000 options to buy
@ $1.08, valued at
$189k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2022 |
4
| Chou William (CEO) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 885,000 options to buy
@ $1.32, valued at
$1.2M
|
|
| 10/12/2022 |
3
| Chou William (CEO) has filed a Form 3 on Passage BIO, Inc. |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Forman Mark S (Chief Medical Officer) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 136,000 options to buy
@ $2.29, valued at
$311.4k
|
|
| 06/15/2022 |
4
| Cale Edgar B. (Interim CEO, GC & Corp. Sec.) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 106,000 options to buy
@ $2.29, valued at
$242.7k
|
|
|